2,4 di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or Syk inhibitors

Details for Australian Patent Application No. 2004272283 (hide)

Owner Novartis AG

Inventors Baenteli, Rolf; Van Eis, Maurice; Hinterding, Klaus; Zenke, Gerhard; Cooke, Nigel Graham; Thoma, Gebhard; Von Matt, Anette; Buehlmayer, Peter; Bernhard, Marie Claude; Duthaler, Rudolf; Walliser, Louis

Agent Davies Collison Cave

Pub. Number AU-B-2004272283

PCT Pub. Number WO2005/026158

Priority 0414440.8 28.06.04 GB; 0321710.6 16.09.03 GB

Filing date 15 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 2 October 2008

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026158 Priority application(s): WO2005/026158

2 October 2008 Application Accepted

  Published as AU-B-2004272283

29 January 2009 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272285-Organic compounds

2004272280-Matrix metalloproteinase inhibitors